Skip to main content

Table 1 WHO-UMC causality categories

From: Clinical characteristics and risk factors for cefaclor-induced immediate hypersensitivity: a retrospective observation at two university hospitals in Korea

Causality term

Assessment criteriaa

Certain

Event or laboratory test abnormality, with plausible time relationship to drug intake

Cannot be explained by disease or other drugs

Response to withdrawal plausible (pharmacologically, pathologically)

Event definitive pharmacologically or phenomenologically (i.e., an objective and specific medical disorder or a recognized pharmacological phenomenon)

Rechallenge satisfactory, if necessary

Probable/likely

Event or laboratory test abnormality, with reasonable time relationship to drug intake

Unlikely to be attributed to disease or other drugs

Response to withdrawal clinically reasonable

Rechallenge not required

Possible

Event or laboratory test abnormality, with reasonable time relationship to drug intake

Could also be explained by disease or other drugs

Information on drug withdrawal may be lacking or unclear

Unlikely

Event of laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible)

Disease or other drugs provide plausible explanations

Conditional/unclassified

Event or laboratory test abnormality

More data for proper assessment needed, or

Additional data under examination

Unassessable/unclassifiable

Report suggesting an adverse reaction

Cannot be judged because information is insufficient or contradictory

Data cannot be supplemented or verified

  1. aAll points should be reasonably complied with